ArticleHealth science reports2026
Dyslipidemia in Pulmonary Tuberculosis Patients Attending Nsawam Adoagyiri Municipal Hospital: Pre- and Post-Anti-Tuberculosis Treatment.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis (TB) remains a significant public health problem in Ghana, with high morbidity and mortality rates. Persons with TB are at risk of adverse cardiovascular disease with hyperlipidemia being a major risk factor. The standard treatment for pulmonary TB includes a combination of anti-tuberculosis drugs such as Rifampicin, Isoniazid, pyrazinamide, and ethambutol which have been associated with changes in lipid profile that could increase the risk of cardiovascular disease. Despite the existence of the links between cholesterol and TB, it is not clear to what extent the treatment of the disease affects lipid indicators in patients with TB, particularly in Ghana. This study, therefore, sought to investigate any differences in the concentration of lipid profile in Pulmonary Tuberculosis patients in Nsawam Adoagyiri Municipality vis-sa-vis pre- and post-anti-tuberculosis treatment. Methods: A cross-sectional survey involving 210 participants was conducted in Nsawam-Adoagyiri Municipal Hospital, in the Eastern Region of Ghana. Data were analyzed using STATA version 17. Categorical variables were presented as numbers (percentages). Continuous variables with normal distribution were expressed as mean ± standard deviation. Inferential statistics were explored using paired Results: The overall dyslipidemia pre- and post-tuberculosis treatment are 69.0% (145/210) and 77.6% (163/210) respectively. The mean Total Cholesterol and LDL increased significantly after the patient had completed the anti-tuberculosis treatment ( Conclusion: These findings suggest that dyslipidemia is quite prevalent among TB patients attending the Nsawam Government Hospital, which may have a negative effect on their health and general well-being. There is a significant difference in the lipid profile results of the participants' overall before and after the TB therapy. Anti-TB treatment needs to develop more advanced recommendations that take patients' lipid levels into account in order to improve the outcomes for TB patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.